Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K T Preissner

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|June 15, 1992
Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formationC Kost, W Stüber, H J Ehrlich, et al.
Thrombosis and Haemostasis|October 1, 1994
Calcium-dependent activation of protein C by thrombin/thrombomudulin: role of negatively charged amino acids within the activation peptide of protein CU Friedrich, B Pötzsch, K T Preissner, et al.
The Journal of Biological Chemistry|June 5, 1991
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activatorJ Keijer, H J Ehrlich, M Linders, et al.
The Journal of Biological Chemistry|March 25, 1990
Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombinK T Preissner, T Koyama, D Müller, et al.
Nature Medicine|May 1, 1996
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularizationH P Hammes, M Brownlee, A Jonczyk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin regulation by physiological inhibitors: the role of vitronectinK T Preissner, H de Boer, H Pannekoek, et al.
Blood|March 1, 1987
Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veinsW Speiser, E Anders, K T Preissner, et al.
Thrombosis and Haemostasis|August 28, 2001
Release of soluble urokinase receptor from vascular cellsT Chavakis, A K Willuweit, F Lupu, et al.
British Journal of Haematology|January 1, 1988
Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuriaA Salama, K T Preissner, B Göttsche, et al.
British Journal of Haematology|December 1, 1993
Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitroJ D Oosting, K T Preissner, R H Derksen, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|June 15, 1992
Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formationC Kost, W Stüber, H J Ehrlich, et al.
Thrombosis and Haemostasis|October 1, 1994
Calcium-dependent activation of protein C by thrombin/thrombomudulin: role of negatively charged amino acids within the activation peptide of protein CU Friedrich, B Pötzsch, K T Preissner, et al.
The Journal of Biological Chemistry|June 5, 1991
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activatorJ Keijer, H J Ehrlich, M Linders, et al.
The Journal of Biological Chemistry|March 25, 1990
Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombinK T Preissner, T Koyama, D Müller, et al.
Nature Medicine|May 1, 1996
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularizationH P Hammes, M Brownlee, A Jonczyk, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin regulation by physiological inhibitors: the role of vitronectinK T Preissner, H de Boer, H Pannekoek, et al.
Blood|March 1, 1987
Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veinsW Speiser, E Anders, K T Preissner, et al.
Thrombosis and Haemostasis|August 28, 2001
Release of soluble urokinase receptor from vascular cellsT Chavakis, A K Willuweit, F Lupu, et al.
British Journal of Haematology|January 1, 1988
Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuriaA Salama, K T Preissner, B Göttsche, et al.
British Journal of Haematology|December 1, 1993
Autoantibodies directed against the epidermal growth factor-like domains of thrombomodulin inhibit protein C activation in vitroJ D Oosting, K T Preissner, R H Derksen, et al.
Pageof 15